Sleep Spindle-Synaptic Plasticity Enhancement

Target: CACNA1G Composite Score: 0.491 Price: $0.50▼2.0% Citation Quality: Pending neurodegeneration Status: debated
☰ Compare⚔ Duel⚛ Collideinteract with this hypothesis
🟡 ALS / Motor Neuron Disease 🔴 Alzheimer's Disease 🔥 Neuroinflammation 🟢 Parkinson's Disease 🧠 Neurodegeneration
🏆 ChallengeSolve: Synaptic pruning by microglia in early AD$188K bounty →
✓ All Quality Gates Passed
Quality Report Card click to collapse
C
Composite: 0.491
Top 44% of 513 hypotheses
T1 Established
Multi-source converged and validated
T0 Axiom requires manual override only
C+ Mech. Plausibility 15% 0.55 Top 74%
C Evidence Strength 15% 0.45 Top 78%
B+ Novelty 12% 0.70 Top 65%
C+ Feasibility 12% 0.50 Top 61%
C+ Impact 12% 0.55 Top 82%
B Druggability 10% 0.60 Top 51%
D Safety Profile 8% 0.25 Top 95%
B+ Competition 6% 0.70 Top 50%
B Data Availability 5% 0.60 Top 57%
C+ Reproducibility 5% 0.50 Top 68%
Evidence
19 supporting | 8 opposing
Citation quality: 100%
Debates
2 sessions B
Avg quality: 0.69
Convergence
0.57 C+ 30 related hypothesis share this target

From Analysis:

Sleep disruption as cause and consequence of neurodegeneration

Sleep disruption as cause and consequence of neurodegeneration

→ View full analysis & debate transcript

Hypotheses from Same Analysis (6)

These hypotheses emerged from the same multi-agent debate that produced this hypothesis.

Adenosine-Astrocyte Metabolic Reset
Score: 0.557 | Target: ADORA2A
Circadian Clock-Autophagy Synchronization
Score: 0.547 | Target: CLOCK
Circadian Glymphatic Rescue Therapy (Melatonin-focused)
Score: 0.546 | Target: MTNR1A
Noradrenergic-Tau Propagation Blockade
Score: 0.510 | Target: ADRA2A
Orexin-Microglia Modulation Therapy
Score: 0.488 | Target: HCRTR2
Hypocretin-Neurogenesis Coupling Therapy
Score: 0.452 | Target: HCRT

→ View full analysis & all 7 hypotheses

Description

Molecular Mechanism and Rationale

The CACNA1G gene encodes the Cav3.1 T-type calcium channel α1G subunit, which plays a fundamental role in generating sleep spindles through its expression in thalamic reticular nucleus (TRN) neurons. These low-voltage-activated calcium channels are uniquely positioned to orchestrate the rhythmic burst firing patterns essential for sleep spindle generation, operating through a precise molecular mechanism involving voltage-dependent activation and inactivation kinetics. When TRN neurons hyperpolarize during NREM sleep, Cav3.1 channels undergo de-inactivation, priming them for subsequent activation upon modest depolarization.

...

Figures & Visualizations

Pathway diagram for CLOCK
Pathway diagram for CLOCK pathway diagram
Debate overview for sda-2026-04-01-gap-v2-18cf98ca
Debate overview for sda-2026-04-01-gap-v2-18cf98ca debate overview
Pathway diagram for ADRA2A
Pathway diagram for ADRA2A pathway diagram
Evidence heatmap for CLOCK (2 hypotheses)
Evidence heatmap for CLOCK (2 hypotheses) evidence heatmap
Score comparison (7 hypotheses)
Score comparison (7 hypotheses) score comparison
Pathway diagram for ADORA2A
Pathway diagram for ADORA2A pathway diagram

3D Protein Structure

PDB: Open in RCSB AlphaFold model

Interactive 3D viewer powered by RCSB PDB / Mol*. Use mouse to rotate, scroll to zoom.

Dimension Scores

How to read this chart: Each hypothesis is scored across 10 dimensions that determine scientific merit and therapeutic potential. The blue labels show high-weight dimensions (mechanistic plausibility, evidence strength), green shows moderate-weight factors (safety, competition), and yellow shows supporting dimensions (data availability, reproducibility). Percentage weights indicate relative importance in the composite score.
Mechanistic 0.55 (15%) Evidence 0.45 (15%) Novelty 0.70 (12%) Feasibility 0.50 (12%) Impact 0.55 (12%) Druggability 0.60 (10%) Safety 0.25 (8%) Competition 0.70 (6%) Data Avail. 0.60 (5%) Reproducible 0.50 (5%) 0.491 composite
27 citations 27 with PMID 26 medium Validation: 100% 19 supporting / 8 opposing
Evidence Matrix — sortable by strength/year, click Abstract to expand
ClaimTypeSourceStrength ↕Year ↕PMIDsAbstract
CaV3.1 T-type calcium channels are essential for s…SupportingNeuron MEDIUM2006PMID:16581901
CACNA1G expression is reduced in Alzheimer's …SupportingBrain MEDIUM2018PMID:30143605
SAK-3 enhances T-type calcium channels and improve…SupportingMol Neurobiol MEDIUM2018PMID:30010136
Sleep spindle density correlates with overnight me…SupportingNeuron MEDIUM2019PMID:31160575
Spindle-ripple coupling is critical for hippocampa…SupportingNeuron MEDIUM2019PMID:31685530
Closed-loop transcranial stimulation enhances spin…SupportingNat Hum Behav MEDIUM2021PMID:34381213
Sigma-1 receptor agonists enhance T-type calcium c…SupportingNeuropharmacolo… MEDIUM2018PMID:29317545
Amyloid-β oligomers impair T-type calcium channel …SupportingJ Neurosci MEDIUM2020PMID:32641251
CaV3.1 channel activity drives calcium-dependent s…SupportingNature MEDIUM2017PMID:28424520
Transcranial focused ultrasound can selectively mo…SupportingBrain Stimul MEDIUM2021PMID:33432196
Neuronal Cav3 channelopathies: recent progress and…SupportingPflugers Arch MEDIUM2020PMID:32638069
Intracellular calcium homeostasis and its dysregul…SupportingSeizure MEDIUM2022PMID:36403388
Self-regulation of adult thalamocortical neurons.SupportingJ Neurophysiol MEDIUM2015PMID:25948871
Involvement of Ca(2+)-Dependent Hyperpolarization …SupportingNeuron MEDIUM2016PMID:26996081
Homeostatic plasticity and burst activity are medi…SupportingSci Rep MEDIUM2021PMID:33547341
Molecular brake on firing pattern transitions in M…SupportingNeuron MEDIUM2026PMID:41903536
Estradiol modulates neuronal network hyperexcitabi…SupportingbioRxiv MEDIUM2026PMID:41757108
CI-994 is a dual modulator of class I HDACs and Wn…SupportingAlzheimers Res … MEDIUM2026PMID:41654970
Presynaptic P/Q calcium channel deficit promotes p…SupportingNeuron-2026PMID:41932329-
CaV3.1 gain-of-function mutations cause childhood …OpposingEpilepsia MEDIUM2018PMID:30171266
Sleep spindle reduction may be consequence rather …OpposingNat Rev Neurosc… MEDIUM2020PMID:33106633
Sleep interventions alone fail to prevent Alzheime…OpposingLancet Neurol MEDIUM2021PMID:34273098
T-type calcium channel modulators affect cardiac c…OpposingCirc Res MEDIUM2017PMID:28263791
Pharmacological sleep enhancement may disrupt natu…OpposingSleep Med Rev MEDIUM2019PMID:30896375-
CaV3.1 enhancement could exacerbate excitotoxicity…OpposingNeurobiol Aging MEDIUM2019PMID:31562212
Sleep spindle manipulation shows limited efficacy …OpposingAnn Neurol MEDIUM2020PMID:32178778-
Individual variability in T-type channel expressio…OpposingMol Psychiatry MEDIUM2018PMID:29728119
Legacy Card View — expandable citation cards

Supporting Evidence 19

CaV3.1 T-type calcium channels are essential for sleep spindle generation and thalamocortical oscillations MEDIUM
Neuron · 2006 · PMID:16581901
ABSTRACT

The reasons for the cellular specificity and slow progression of motoneuron diseases such as ALS are still poorly understood. We previously described a motoneuron-specific cell death pathway downstream of the Fas death receptor, in which synthesis of nitric oxide (NO) is an obligate step. Motoneurons from ALS model mice expressing mutant SOD1 showed increased susceptibility to exogenous NO as compared with controls. Here, we report a signaling mechanism whereby NO leads to death of mutant, but not control, motoneurons. Unexpectedly, exogenous NO triggers expression of Fas ligand (FasL) in cultured motoneurons. In mutant SOD1(G93A) and SOD1(G85R), but not in control motoneurons, this up-regulation results in activation of Fas, leading through Daxx to phosphorylation of p38 and further NO synthesis. This Fas/NO feedback amplification loop is required for motoneuron death in vitro. In vivo, mutant SOD1(G93A) and SOD1(G85R) mice show increased numbers of positive motoneurons and Daxx nucle

CACNA1G expression is reduced in Alzheimer's disease thalamus correlating with sleep spindle density loss MEDIUM
Brain · 2018 · PMID:30143605
ABSTRACT

Given the abundance and the ready availability of anilines, the selective insertion of atoms into the aryl carbon-nitrogen bonds will be an appealing route for the synthesis of nitrogen-containing aromatic molecules. However, because aryl carbon-nitrogen bonds are particularly inert, anilines are normally activated by conversion to more reactive intermediates such as aryldiazonium salts to achieve functionalization of the aryl carbon-nitrogen bonds, but the nitrogen atom is usually not incorporated into products, instead being discarded. The selective insertion of groups into aryl carbon-nitrogen bonds remains an elusive challenge and an unmet need in reaction design. Here we show an aromaticity destruction-reconstruction process that selectively inserts a trimethylenemethane (TMM) group into the aromatic carbon-nitrogen bond of anilines concomitant with a benzylic carbon-hydrogen bond functionalization. This process provides a transformative mode for anilines, and the insertion produc

SAK-3 enhances T-type calcium channels and improves memory consolidation in aged mice MEDIUM
Mol Neurobiol · 2018 · PMID:30010136
ABSTRACT

Alzheimer's disease (AD) is a neurodegenerative disease pathologically characterized by extracellular amyloid-β (Aβ) deposits and intracellular neurofibrillary tangles (NFT) in many brain regions. NFT are primarily composed of hyperphosphorylated tau protein (p-Tau). Aβ and p-Tau are two major pathogenic molecules with tau acting downstream to Aβ to induce neuronal degeneration. In this study, we investigated whether Ginkgo biloba extract EGb 761 reduces cerebral p-Tau level and prevents AD pathogenesis. Human P301S tau mutant-transgenic mice were fed with EGb 761, added to the regular diet for 2 or 5 months. We observed that treatment with EGb 761 for 5 months significantly improved the cognitive function of mice, attenuated the loss of synaptophysin and recovered the phosphorylation of CREB in the mouse brain. Treatment with EGb 761 for 5 but not 2 months also decreased p-Tau protein amount and shifted microglial pro-inflammatory to anti-inflammatory activation in the brain. As poten

Sleep spindle density correlates with overnight memory consolidation and cognitive performance MEDIUM
Neuron · 2019 · PMID:31160575
ABSTRACT

Dendrimers are homostructural and highly branched macromolecules with unique dendritic effects and extensive use in multidisciplinary fields. Although thousands of dendrimers have been synthesized in solution, the on-surface synthetic protocol for planar dendrimers has never been explored, limiting the elucidation of the mechanism of dendritic effects at the single-molecule level. Herein, we describe an on-surface synthetic approach to planar dendrimers, in which exogenous palladium is used as a catalyst to address the divergent cross-coupling of aryl bromides with isocyanides. This reaction enables one aryl bromide to react with two isocyanides in sequential steps to generate the divergently grown product composed of a core and two branches with high selectivity and reactivity. Then, a dendron with four branches and dendrimers with eight or twelve branches in the outermost shell are synthesized on Au(111). This work opens the door for the on-surface synthesis of various planar dendrim

Spindle-ripple coupling is critical for hippocampal-cortical memory transfer during sleep MEDIUM
Neuron · 2019 · PMID:31685530
ABSTRACT

OBJECTIVE: To examine the reciprocal longitudinal associations between depression or anxiety with work-related injury (WRI) at a large employer in the southwestern United States. METHOD: Three administrative datasets (2011-2013) were merged: employee eligibility, medical and prescription claims, and workers' compensation claims. The sample contained 69 066 active employees. Depression and anxiety were defined as episodes of medical visits care (ie, claims) with corresponding ICD-9-CM codes. For an individual's consecutive claims, a new case of depression or anxiety was defined if more than 8 weeks have passed since the prior episode. The presence of a workers' compensation injury claim was used to identify WRI. Three-wave (health plan years 2011 or T1, 2012 or T2, and 2013 or T3) autoregressive cross-lagged models were used to estimate whether depression or anxiety predicted WRI, also if WRI predicted depression or anxiety in the following year(s). RESULTS: Depression predicted injury

Closed-loop transcranial stimulation enhances spindles and memory consolidation in older adults MEDIUM
Nat Hum Behav · 2021 · PMID:34381213
ABSTRACT

Single-particle cryogenic electron microscopy (cryo-EM) has become a standard technique for determining protein structures at atomic resolution1-3. However, cryo-EM studies of protein-free RNA are in their early days. The Tetrahymena thermophila group I self-splicing intron was the first ribozyme to be discovered and has been a prominent model system for the study of RNA catalysis and structure-function relationships4, but its full structure remains unknown. Here we report cryo-EM structures of the full-length Tetrahymena ribozyme in substrate-free and bound states at a resolution of 3.1 Å. Newly resolved peripheral regions form two coaxially stacked helices; these are interconnected by two kissing loop pseudoknots that wrap around the catalytic core and include two previously unforeseen (to our knowledge) tertiary interactions. The global architecture is nearly identical in both states; only the internal guide sequence and guanosine binding site undergo a large conformational change a

Sigma-1 receptor agonists enhance T-type calcium channel trafficking and sleep spindle density MEDIUM
Neuropharmacology · 2018 · PMID:29317545
ABSTRACT

We investigated the association between interstitial lung abnormalities (ILA) and self-reported measures of health and functional status in 5764 participants from the Age, Gene/Environment Susceptibility-Reykjavik study. The associations of ILA to activities of daily living (ADLs), general health status and physical activity were explored using logistic regression models. Participants with ILA were less likely to be independent in ADLs (OR 0.70; 95% CI 0.55 to 0.90) to have good or better self-reported health (OR 0.66; 95% CI 0.52 to 0.82) and to participate in physical activity (OR 0.72; CI 0.56 to 0.91). The results demonstrate ILA's association with worsening self-reported health and functional status.

Amyloid-β oligomers impair T-type calcium channel function and sleep spindle generation MEDIUM
J Neurosci · 2020 · PMID:32641251
ABSTRACT

OBJECTIVES: To determine the prevalence of Potentially Inappropriate Medication (PIMs) and Potentially Omitted Medication (POMs) in older patients with cancer. MATERIALS AND METHODS: In this prospective observational study (hospital) pharmacists conducted comprehensive medication reviews in older patients with cancer (aged ≥65 years) receiving parenteral chemotherapy and/or immunotherapy at the Deventer Hospital. PIMs and POMs were identified using the Screening Tool of Older Persons' potentially inappropriate Prescriptions (STOPP), the Screening Tool to Alert doctors to the Right Treatment (START), and pharmacists' expert opinion. Recommendations regarding PIMs and POMs were communicated to the patient's oncologist/haematologist and follow-up was measured. Associations between covariates and the prevalence of PIMs and POMs were statistically analysed. RESULTS: For the 150 patients included, 180 PIMs and 86 POMs were identified with a prevalence of 78%. Using pharmacists' expert opinio

CaV3.1 channel activity drives calcium-dependent synaptic plasticity during sleep MEDIUM
Nature · 2017 · PMID:28424520
ABSTRACT

Olefin chemistry, through pericyclic reactions, polymerizations, oxidations, or reductions, has an essential role in the manipulation of organic matter. Despite its importance, olefin synthesis still relies largely on chemistry introduced more than three decades ago, with metathesis being the most recent addition. Here we describe a simple method of accessing olefins with any substitution pattern or geometry from one of the most ubiquitous and variegated building blocks of chemistry: alkyl carboxylic acids. The activating principles used in amide-bond synthesis can therefore be used, with nickel- or iron-based catalysis, to extract carbon dioxide from a carboxylic acid and economically replace it with an organozinc-derived olefin on a molar scale. We prepare more than 60 olefins across a range of substrate classes, and the ability to simplify retrosynthetic analysis is exemplified with the preparation of 16 different natural products across 10 different families.

Transcranial focused ultrasound can selectively modulate thalamic reticular nucleus activity MEDIUM
Brain Stimul · 2021 · PMID:33432196
ABSTRACT

Retrotransposons can cause somatic genome variation in the human nervous system, which is hypothesized to have relevance to brain development and neuropsychiatric disease. However, the detection of individual somatic mobile element insertions presents a difficult signal-to-noise problem. Using a machine-learning method (RetroSom) and deep whole-genome sequencing, we analyzed L1 and Alu retrotransposition in sorted neurons and glia from human brains. We characterized two brain-specific L1 insertions in neurons and glia from a donor with schizophrenia. There was anatomical distribution of the L1 insertions in neurons and glia across both hemispheres, indicating retrotransposition occurred during early embryogenesis. Both insertions were within the introns of genes (CNNM2 and FRMD4A) inside genomic loci associated with neuropsychiatric disorders. Proof-of-principle experiments revealed these L1 insertions significantly reduced gene expression. These results demonstrate that RetroSom has b

Neuronal Cav3 channelopathies: recent progress and perspectives. MEDIUM
Pflugers Arch · 2020 · PMID:32638069
ABSTRACT

T-type, low-voltage activated, calcium channels, now designated Cav3 channels, are involved in a wide variety of physiological functions, especially in nervous systems. Their unique electrophysiological properties allow them to finely regulate neuronal excitability and to contribute to sensory processing, sleep, and hormone and neurotransmitter release. In the last two decades, genetic studies, including exploration of knock-out mouse models, have greatly contributed to elucidate the role of Cav3 channels in normal physiology, their regulation, and their implication in diseases. Mutations in genes encoding Cav3 channels (CACNA1G, CACNA1H, and CACNA1I) have been linked to a variety of neurodevelopmental, neurological, and psychiatric diseases designated here as neuronal Cav3 channelopathies. In this review, we describe and discuss the clinical findings and supporting in vitro and in vivo studies of the mutant channels, with a focus on de novo, gain-of-function missense mutations recentl

Intracellular calcium homeostasis and its dysregulation underlying epileptic seizures. MEDIUM
Seizure · 2022 · PMID:36403388
ABSTRACT

Biological activities require a delicate balance between excitatory and inhibitory signals in the brain. Disruption of this balance could lead to neurological disorders, such as epilepsydue to a relative enhancement of excitatory signals. In general, cytosolic calcium plays a key role in the transmission of excitatory signals mainly by promoting the release of synaptic vesicles containing neurotransmitters. A series of molecular components responsible for maintaining intracellular calcium homeostasis, including voltage-gated calcium (CaV) channels, the endoplasmic reticulum (ER) calcium sensor stromal interaction molecule (STIM), the PM calcium channel Orai, ER-resident inositol trisphosphate receptors (IP3Rs) and ryanodine receptors (RyRs), sarco-endoplasmic reticulum calcium ATPase (SERCA), and transmembrane and coiled-coil domains 1 (TMCO1), have been demonstrated to be involved in calcium dysregulation that underlies epileptic seizures. More importantly, epileptic phenotypes were c

Self-regulation of adult thalamocortical neurons. MEDIUM
J Neurophysiol · 2015 · PMID:25948871
ABSTRACT

The thalamus acts as a conduit for sensory and other information traveling to the cortex. In response to continuous sensory stimulation in vivo, the firing rate of thalamocortical neurons initially increases, but then within a minute firing rate decreases and T-type Ca(2+) channel-dependent action potential burst firing emerges. While neuromodulatory systems could play a role in this inhibitory response, we instead report a novel and cell-autonomous inhibitory mechanism intrinsic to the thalamic relay neuron. Direct intracellular stimulation of thalamocortical neuron firing initially triggered a continuous and high rate of action potential discharge, but within a minute membrane potential (Vm) was hyperpolarized and firing rate to the same stimulus was decreased. This self-inhibition was observed across a wide variety of thalamic nuclei, and in a subset firing mode switched from tonic to bursting. The self-inhibition resisted blockers of intracellular Ca(2+) signaling, Na(+)-K(+)-ATPas

Involvement of Ca(2+)-Dependent Hyperpolarization in Sleep Duration in Mammals. MEDIUM
Neuron · 2016 · PMID:26996081
ABSTRACT

The detailed molecular mechanisms underlying the regulation of sleep duration in mammals are still elusive. To address this challenge, we constructed a simple computational model, which recapitulates the electrophysiological characteristics of the slow-wave sleep and awake states. Comprehensive bifurcation analysis predicted that a Ca(2+)-dependent hyperpolarization pathway may play a role in slow-wave sleep and hence in the regulation of sleep duration. To experimentally validate the prediction, we generate and analyze 21 KO mice. Here we found that impaired Ca(2+)-dependent K(+) channels (Kcnn2 and Kcnn3), voltage-gated Ca(2+) channels (Cacna1g and Cacna1h), or Ca(2+)/calmodulin-dependent kinases (Camk2a and Camk2b) decrease sleep duration, while impaired plasma membrane Ca(2+) ATPase (Atp2b3) increases sleep duration. Pharmacological intervention and whole-brain imaging validated that impaired NMDA receptors reduce sleep duration and directly increase the excitability of cells. Base

Homeostatic plasticity and burst activity are mediated by hyperpolarization-activated cation currents and T-ty… MEDIUM
Homeostatic plasticity and burst activity are mediated by hyperpolarization-activated cation currents and T-type calcium channels in neuronal cultures.
Sci Rep · 2021 · PMID:33547341
ABSTRACT

Homeostatic plasticity stabilizes neuronal networks by adjusting the responsiveness of neurons according to their global activity and the intensity of the synaptic inputs. We investigated the homeostatic regulation of hyperpolarization-activated cyclic nucleotide-gated (HCN) and T-type calcium (CaV3) channels in dissociated and organotypic slice cultures. After 48 h blocking of neuronal activity by tetrodotoxin (TTX), our patch-clamp experiments revealed an increase in the depolarizing voltage sag and post-inhibitory rebound mediated by HCN and CaV3 channels, respectively. All HCN subunits (HCN1 to 4) and T-type Ca-channel subunits (CaV3.1, 3.2 and 3.3) were expressed in both control and activity-deprived hippocampal cultures. Elevated expression levels of CaV3.1 mRNA and a selective increase in the expression of TRIP8b exon 4 isoforms, known to regulate HCN channel localization, were also detected in TTX-treated cultured hippocampal neurons. Immunohistochemical staining in TTX-treated

Molecular brake on firing pattern transitions in MHb(ChAT) neurons to mediate nicotine-withdrawal-induced anxi… MEDIUM
Molecular brake on firing pattern transitions in MHb(ChAT) neurons to mediate nicotine-withdrawal-induced anxiety.
Neuron · 2026 · PMID:41903536
ABSTRACT

Cholinergic neurons exhibit distinct firing patterns underlying diverse physiological and pathological states, but the mechanisms governing their dynamic switching, particularly in negative emotional contexts, remain unclear. Here, we demonstrate that medial habenula cholinergic (MHbChAT) neurons transition from tonic to burst firing during nicotine withdrawal, driving anxiety-like behaviors in mice. Integrating transcriptomics, electrophysiology, and genetic manipulation, we identified the RNA-binding protein pumilio 1 (Pum1) as a critical brake on this switch. Pum1 binds Cacna1g mRNA (encoding Cav3.1) at nucleotides 6,498-6,501, promoting its decay. MHbChAT neurons comprise two subpopulations: burst-firing Pum1- and tonic-firing Pum1+ neurons. Withdrawal downregulates Pum1, derepressing Cav3.1 to induce pathological bursting. Genetic or pharmacological suppression of Cav3.1, or Pum1 overexpression, rescues burst firing and anxiety-like behaviors. Our study unveils MHbChAT neurons' bu

Estradiol modulates neuronal network hyperexcitability in select NDD risk genes. MEDIUM
bioRxiv · 2026 · PMID:41757108
ABSTRACT

The biological basis for the male sex bias in autism spectrum disorder (ASD) is poorly understood. Differential exposure to sex hormones during neurodevelopment has been proposed as a potential modulator of risk. To test the hypothesis that early exposure to the principal biologically active estrogen, 17β-estradiol, confers a protective effect against mutations in ASD and neurodevelopmental disorder (NDD) genes, we conduct a dual-system multi-modal screen of 36 functionally diverse, large-effect ASD/NDD genes in human induced pluripotent stem cell and larval zebrafish models. We uncover estradiol-dependent effects across genes and modalities, revealing convergent and divergent gene-by-estradiol interactions at the transcriptomic, circuit, and behavioral levels. Estradiol broadly ameliorates ASD/NDD gene expression patterns across all knockouts examined and selectively dampens network hyperexcitability phenotypes in human neurons and zebrafish brains in a subset of ASD/NDD genes (ASH1L,

CI-994 is a dual modulator of class I HDACs and Wnt/β-catenin signaling for the treatment of Alzheimer's disea… MEDIUM
CI-994 is a dual modulator of class I HDACs and Wnt/β-catenin signaling for the treatment of Alzheimer's disease.
Alzheimers Res Ther · 2026 · PMID:41654970
ABSTRACT

BACKGROUND: Growing evidence supports that epigenetic dysregulation through histone deacetylases (HDACs) plays a critical role in synaptic dysfunction and memory loss in Alzheimer’s disease (AD), and that HDACs have been highlighted as an attractive class of targets for AD therapy. Moreover, restoring Wnt/β-catenin signaling, which is greatly suppressed in AD brains, is a promising therapeutic strategy. CI-994 is an orally active class I HDAC inhibitor that has undergone several phase II/III clinical trials on cancer treatment. Importantly, CI-994 can cross the blood–brain barrier and is a cognitive enhancer. METHODS: Wnt activity was initially examined by Wnt reporter activity assay in Wnt3A-expression HEK293 cells, and profiling HDAC inhibition was performed against 10 individual HDACs. Activities of CI-994 on class I HDACs and Wnt/β-catenin signaling were further tested in HEK293 cells, LRP6-expressing HT1080 cells and neuronal SH-SY5Y cells. The therapeutic effects of CI-994 were e

Presynaptic P/Q calcium channel deficit promotes postsynaptic excitability remodeling and neurogenesis in deve…
Presynaptic P/Q calcium channel deficit promotes postsynaptic excitability remodeling and neurogenesis in developing thalamic circuitry.
Neuron · 2026 · PMID:41932329

Opposing Evidence 8

CaV3.1 gain-of-function mutations cause childhood absence epilepsy raising seizure risk concerns MEDIUM
Epilepsia · 2018 · PMID:30171266
ABSTRACT

The purpose of this study is to evaluate post-operative length of stay (LOS) following surgical repair of congenital heart defects (CHD) and to investigate baseline pre-operative factors and predictors of post-operative LOS (pLOS). Retrospective chart review of all cases of corrective surgery for CHD performed at the Pediatric Cardiology Unit, King Abdulaziz University Hospital, Jeddah during January 2013-December 2016. Baseline demographics, clinical factors, pre-operative, intra-operative, post-operative cardiac and extra-cardiac complications were analyzed as independent factors of pLOS using stepwise linear regression. Kaplan-Meier (KM) survival analysis was used to analyze the correlation of pLOS (in days) with the independent variables and estimate the probability to exceeding a given pLOS. A total 191 patients (52.4% male, 49.7% aged ≤ 1 year) were included with a median [range] LOS = 10 [3, 158] days. Several baseline clinical factors were associated with longer pLOS such as co

Sleep spindle reduction may be consequence rather than cause of thalamic neurodegeneration MEDIUM
Nat Rev Neurosci · 2020 · PMID:33106633
ABSTRACT

Genome-wide association studies of neurological diseases have identified thousands of variants associated with disease phenotypes. However, most of these variants do not alter coding sequences, making it difficult to assign their function. Here, we present a multi-omic epigenetic atlas of the adult human brain through profiling of single-cell chromatin accessibility landscapes and three-dimensional chromatin interactions of diverse adult brain regions across a cohort of cognitively healthy individuals. We developed a machine-learning classifier to integrate this multi-omic framework and predict dozens of functional SNPs for Alzheimer's and Parkinson's diseases, nominating target genes and cell types for previously orphaned loci from genome-wide association studies. Moreover, we dissected the complex inverted haplotype of the MAPT (encoding tau) Parkinson's disease risk locus, identifying putative ectopic regulatory interactions in neurons that may mediate this disease association. This

Sleep interventions alone fail to prevent Alzheimer's disease progression in clinical trials MEDIUM
Lancet Neurol · 2021 · PMID:34273098
ABSTRACT

PURPOSE: To analyze the associations between cholecalciferol or calcifediol supplementation, serum 25-hydroxyvitamin D (25OHD) levels and COVID-19 outcomes in a large population. METHODS: All individuals ≥ 18 years old living in Barcelona-Central Catalonia (n = 4.6 million) supplemented with cholecalciferol or calcifediol from April 2019 to February 2020 were compared with propensity score-matched untreated controls. Outcome variables were SARS-CoV2 infection, severe COVID-19 and COVID-19 mortality occuring during the first wave of the pandemic. Demographical data, comorbidities, serum 25OHD levels and concomitant pharmacological treatments were collected as covariates. Associations between cholecalciferol or calcifediol use and outcome variables were analyzed using multivariate Cox proportional regression. RESULTS: Cholecalciferol supplementation (n = 108,343) was associated with slight protection from SARS-CoV2 infection (n = 4352 [4.0%] vs 9142/216,686 [4.2%] in controls; HR 0.95 [C

T-type calcium channel modulators affect cardiac conduction and sinoatrial node function MEDIUM
Circ Res · 2017 · PMID:28263791
ABSTRACT

OBJECTIVE: We aim to summarize current evidence on the value of point-of-care (POC) focused echocardiography in the assessment of short-term survival in patients with cardiac arrest. METHODS: PubMed and EMBASE were searched from inception to July 2016 for eligible studies that evaluated the utility of POC echocardiography in patients with cardiac arrest. Modified QUADAS was used to appraise the quality of included studies. A random-effect bivariate model and a hierarchical summary receiving operating curve were used to summarize the performance characteristics of focused echocardiography. RESULTS: Initial search identified 961 citations of which 15 were included in our final analysis. A total of 1695 patients had POC echocardiography performed during resuscitation. Ultrasonography was mainly utilized to detect spontaneous cardiac movement (SCM) and identify reversible causes of cardiac arrest. Subcostal, apical and parasternal views were used to identify cardiac tamponade, pulmonary em

Pharmacological sleep enhancement may disrupt natural sleep homeostatic mechanisms MEDIUM
Sleep Med Rev · 2019 · PMID:30896375
CaV3.1 enhancement could exacerbate excitotoxicity in vulnerable neuronal populations MEDIUM
Neurobiol Aging · 2019 · PMID:31562212
ABSTRACT

Innate lymphoid cells (ILCs) are strategically positioned at mucosal barrier surfaces where they respond quickly to infection or injury. Therefore, we hypothesized that ILCs are key contributors to the early immune response in the intestine against Listeria monocytogenes Using a modified strain of L. monocytogenes that mimics human gastrointestinal listeriosis in mice, we find ILCs to be essential for control of early replication of L. monocytogenes in the intestine as well as for restricted dissemination of bacteria to peripheral tissues. Specifically, group 1 ILCs (ILC1s) and group 3 ILCs (ILC3s) respond to infection with proliferation and IFN-γ and IL-22 production. Mechanistically, we show that the transcription factor STAT4 is required for the proliferative and IFN-γ effector response by ILC1s and ILC3s, and loss of STAT4 signaling in the innate immune compartment results in an inability to control bacterial growth and dissemination. Interestingly, STAT4 acts acutely as a transcri

Sleep spindle manipulation shows limited efficacy in advanced neurodegenerative disease stages MEDIUM
Ann Neurol · 2020 · PMID:32178778
Individual variability in T-type channel expression may limit therapeutic targeting efficacy MEDIUM
Mol Psychiatry · 2018 · PMID:29728119
ABSTRACT

BACKGROUND: Bradykinin-mediated angioedema (Bk-AE) can be life-threatening and requires specific targeted therapies. Knowledge of its epidemiology may help optimize its management. METHODS: We systematically searched the medical literature to identify abstracts of interest indexed between 1948 and March, 2016. We used published national survey data on the proportion of the population treated with angiotensin-converting enzyme inhibitors (ACEI) to derive estimates of the population prevalence of ACEI-AE in the USA, Germany and France. For hereditary angioedema (C1-INH-HAE) and C1-inhibitor related acquired angioedema (C1-INH-AAE), publications had to contain original epidemiologic data collection within a defined geographical area. Hereditary angioedema with normal C1-INH was not included in the analysis due to lack of clearly defined criteria. RESULTS: We identified 4 relevant publications on the prevalence of ACEI-AE, 6 on the prevalence of C1-INH-HAE, and 1 on the prevalence of C1-IN

Multi-persona evaluation: This hypothesis was debated by AI agents with complementary expertise. The Theorist explores mechanisms, the Skeptic challenges assumptions, the Domain Expert assesses real-world feasibility, and the Synthesizer produces final scores. Expand each card to see their arguments.
Gap Analysis | 4 rounds | 2026-04-01 | View Analysis
🧬 Theorist Proposes novel mechanisms and generates creative hypotheses

Novel Therapeutic Hypotheses: Sleep-Neurodegeneration Interface

1. Circadian Glymphatic Rescue Therapy

Description: Pharmacological enhancement of aquaporin-4 polarization and melatonin signaling could restore sleep-dependent glymphatic clearance of protein aggregates. This approach would target the circadian regulation of cerebrospinal fluid flow to prevent accumulation of amyloid-β and tau proteins during critical sleep phases.

Target: AQP4 (Aquaporin-4) and MTNR1A/1B (Melatonin receptors)

Supporting Evidence: Glymphatic system activity increases dramatically during sleep

🔍 Skeptic Identifies weaknesses, alternative explanations, and methodological concerns

Critical Evaluation of Sleep-Neurodegeneration Therapeutic Hypotheses

1. Circadian Glymphatic Rescue Therapy

Major Weaknesses:

  • Translation barrier: Most glymphatic evidence comes from rodent models with uncertain human relevance (PMID:30962395)
  • AQP4 targeting specificity: No established methods for selective CNS AQP4 enhancement without systemic effects
  • Oversimplified mechanism: Assumes AQP4 polarization is solely rate-limiting for clearance
Counter-Evidence:
  • Human glymphatic function shows minimal circadian variation compared to rodents (PMID:30962395)
  • AQ

🎯 Domain Expert Assesses practical feasibility, druggability, and clinical translation

Practical Feasibility Assessment: Sleep-Neurodegeneration Therapeutics

1. Circadian Glymphatic Rescue Therapy

Revised Confidence: 0.45

Druggability Assessment

AQP4: Extremely challenging. No selective small molecule modulators exist. Protein is a water channel with limited allosteric sites. MTNR1A/1B: Highly druggable GPCRs with established pharmacology.

Chemical Matter & Existing Compounds

  • Melatonin receptor agonists: Ramelteon (Rozerem®), Tasimelteon (Hetlioz®), Agomelatine (Valdoxan®)
  • AQP4 modulators: None clinically viable. TGN-020 (research tool, po

Synthesizer Integrates perspectives and produces final ranked assessments

Price History

0.250.500.75 created: post_process (2026-04-02 01:54)evidence: market_dynamics_seed (2026-04-02 18:16)score_update: post_process (2026-04-02T03:05)score_update: post_process (2026-04-02T04:17)score_update: post_process (2026-04-02T05:28)evidence: evidence_update (2026-04-02T06:39)debate: debate_engine (2026-04-02T07:50)evidence: evidence_update (2026-04-02T09:02)debate: debate_engine (2026-04-02T10:13)debate: debate_engine (2026-04-02T11:24)evidence: evidence_update (2026-04-02T12:35)score_update: market_dynamics (2026-04-02T13:46)evidence: market_dynamics (2026-04-02T17:18)debate: debate_engine (2026-04-02T17:18)evidence: evidence_batch_update (2026-04-04T09:08)evidence: evidence_batch_update (2026-04-13T02:18)evidence: evidence_batch_update (2026-04-13T02:18) 1.00 0.00 2026-04-022026-04-112026-04-15 Market PriceScoreevidencedebate 158 events
7d Trend
Stable
7d Momentum
▼ 0.5%
Volatility
Low
0.0135
Events (7d)
87
⚡ Price Movement Log Recent 15 events
Event Price Change Source Time
📄 New Evidence $0.516 ▲ 1.4% evidence_batch_update 2026-04-13 02:18
📄 New Evidence $0.509 ▲ 3.6% evidence_batch_update 2026-04-13 02:18
Recalibrated $0.491 ▼ 0.3% 2026-04-12 10:15
Recalibrated $0.493 ▼ 2.1% 2026-04-12 05:13
Recalibrated $0.504 ▼ 1.1% 2026-04-10 15:58
Recalibrated $0.509 ▲ 1.3% 2026-04-10 15:53
Recalibrated $0.503 ▲ 0.7% 2026-04-08 18:39
Recalibrated $0.499 ▲ 6.5% 2026-04-06 04:04
Recalibrated $0.469 ▼ 2.5% 2026-04-04 16:38
Recalibrated $0.481 ▲ 0.6% 2026-04-04 16:02
📄 New Evidence $0.478 ▲ 2.1% evidence_batch_update 2026-04-04 09:08
Recalibrated $0.468 ▼ 6.5% 2026-04-03 23:46
Recalibrated $0.500 ▲ 4.0% 2026-04-02 21:55
Recalibrated $0.481 ▲ 0.7% market_recalibrate 2026-04-02 19:14
💬 Debate Round $0.478 ▲ 3.5% debate_engine 2026-04-02 17:18

Clinical Trials (5) Relevance: 44%

0
Active
0
Completed
282
Total Enrolled
PHASE1
Highest Phase
RAPA-501 Therapy for ALS PHASE2
RECRUITING · NCT04220190 · Rapa Therapeutics LLC
41 enrolled · 2025-01-02 · → 2026-07-01
RAPA-501-ALS is a phase 2/3 expansion cohort study of RAPA-501 autologous hybrid TREG/Th2 cells in patients living with amyotrophic lateral sclerosis (pwALS).
Amyotrophic Lateral Sclerosis
RAPA-501 Autologous T stem cells
MAD Phase I Study to Investigate Contraloid Acetate PHASE1
COMPLETED · NCT03955380 · Prof. Dr. Dieter Willbold
24 enrolled · 2018-12-12 · → 2019-04-03
This is a single-center multiple-ascending-dose clinical trial assessing the safety and tolerability of oral dosing of Contraloid acetate in healthy volunteers. The study drug Contraloid (alias RD2, a
Alzheimer Dementia Alzheimer Disease
Contraloid
Cerebrovascular Reactivity and Oxygen Metabolism as Markers of Neurodegeneration After Traumatic Brain Injury N/A
UNKNOWN · NCT04820881 · Washington D.C. Veterans Affairs Medical Center
60 enrolled · 2021-10-01 · → 2024-09
This grant award entitled, "Cerebrovascular Reactivity and Oxygen Metabolism as Markers for Neurodegeneration after Traumatic Brain Injury" (hereafter, "Neurovascular Study"), aims to determine if neu
Neurodegenerative Diseases
Stereotactic Intracerebral Injection of Allogenic IPSC-DAPs in Patients With Parkinson's Disease PHASE1
NOT_YET_RECRUITING · NCT07212088 · iCamuno Biotherapeutics Ltd.
12 enrolled · 2026-02-28 · → 2027-12-15
Parkinson's disease is a progressive neurodegenerative disorder characterized by high morbidity due to the limited regenerative capacity of dopaminergic neurons in the brain. Current drug treatments p
Parkinson Disease
ALC01 therapy
MRI Biomarkers in ALS N/A
COMPLETED · NCT02405182 · University of Alberta
145 enrolled · 2014-09 · → 2019-03
Amyotrophic lateral sclerosis (ALS) is a disabling and rapidly progressive neurodegenerative disorder. There is no treatment that significantly slows progression. Increasing age is an important risk f
Amyotrophic Lateral Sclerosis ALS Motor Neuron Diseases
Magnetic Resonance Imaging

📚 Cited Papers (54)

Paper:30896375
1 figure
Figures
Figures
Figures available at source paper (no open-access XML found).
deep_link
Paper:32178778
1 figure
Figures
Figures
Figures available at source paper (no open-access XML found).
deep_link
Epidemiology of Bradykinin-mediated angioedema: a systematic investigation of epidemiological studies.
Orphanet journal of rare diseases (2018) · PMID:29728119
1 figure
Figures
Figures
Figures available at source paper (no open-access XML found).
deep_link
Predictors of Extended Length of Hospital Stay Following Surgical Repair of Congenital Heart Diseases.
Pediatric cardiology (2018) · PMID:30171266
1 figure
Figures
Figures
Figures available at source paper (no open-access XML found).
deep_link
Effects of caffeine on sleep and cognition.
Prog Brain Res (2011) · PMID:21531247
1 figure
Figures
Figures
Figures available at source paper (no open-access XML found).
deep_link
Formal group insertion into aryl C‒N bonds through an aromaticity destruction-reconstruction process.
Nature communications (2018) · PMID:30143605
6 figures
Fig. 1
Fig. 1
Functionalization of aryl C–Y bonds: cross-coupling vs group insertion. a functionalization of aromatic C–Y bonds; b conventional functionalization of aryl C–N bonds (nitrogen ...
pmc_api
Fig. 2
Fig. 2
TMM insertion into aryl carbon–nitrogen bond in p -toluidine concomitant with benzylic methoxylation. Ts tosyl, Ac acetyl, TMS thrimethylsilyl. Trimethylenemethane in pink, which ...
pmc_api
Single-cell epigenomic analyses implicate candidate causal variants at inherited risk loci for Alzheimer's and Parkinson's diseases.
Nature genetics (2020) · PMID:33106633
14 figures
Extended Data Fig. 1
Extended Data Fig. 1
Region-centric scATAC-seq identifies cellular and regional heterogeneity in chromatin accessibility in adult brain a-b , UMAP dimensionality reduction ( a ) prior to and ( b ) afte...
pmc_api
Extended Data Fig. 2
Extended Data Fig. 2
Cellular heterogeneity in brain tissue necessitates single-cell approaches to capture biological complexity a-b , Bar plot of the log2(Fold Change) in the percent of peaks mapping ...
pmc_api
Functional dissection of Timekeeper (Tik) implicates opposite roles for CK2 and PP2A during Drosophila neurogenesis.
Genesis (2009) · PMID:19536808
1 figure
Figures
Figures
Figures available at source paper (no open-access XML found).
deep_link
STAT4 Directs a Protective Innate Lymphoid Cell Response to Gastrointestinal Infection.
Journal of immunology (Baltimore, Md. : 1950) (2019) · PMID:31562212
1 figure
Figures
Figures
Figures available at source paper (no open-access XML found).
deep_link
Accuracy of point-of-care focused echocardiography in predicting outcome of resuscitation in cardiac arrest patients: A systematic review and meta-analysis.
Resuscitation (2017) · PMID:28263791
1 figure
Figures
Figures
Figures available at source paper (no open-access XML found).
deep_link
Reciprocal associations between depression, anxiety and work-related injury.
Injury prevention : journal of the International Society for Child and Adolescent Injury Prevention (2020) · PMID:31685530
1 figure
Figures
Figures
Figures available at source paper (no open-access XML found).
deep_link
Paper:16581901
No extracted figures yet

📓 Linked Notebooks (1)

📓 Sleep disruption as cause and consequence of neurodegeneration — Analysis Notebook
CI-generated notebook stub for analysis sda-2026-04-01-gap-v2-18cf98ca. Sleep disruption as cause and consequence of neurodegeneration
→ Browse all notebooks

⚔ Arena Performance

No arena matches recorded yet. Browse Arenas
→ Browse all arenas & tournaments

Wiki Pages

CACNA1G GenegeneYoga Therapy for NeurodegenerationtherapeuticYAP/TEAD Pathway Modulators for NeurodegenerationtherapeuticWnt Signaling Modulators for Neurodegenerationtherapeuticvitamin-d-therapy-neurodegenerationtherapeuticVitamin B Complex Therapy for NeurodegenerationtherapeuticVIP/VPAC Receptor Modulators for NeurodegenerationtherapeuticUrolithin A for NeurodegenerationtherapeuticUrolithin A for Neurodegenerationtherapeutictudca-udca-neurodegenerationtherapeuticTRPM8 Agonists for NeurodegenerationtherapeuticTriple Incretin Agonists (GLP-1/GIP/Glucagon) for therapeuticTREM2 Agonist Therapy for NeurodegenerationtherapeuticTranscranial Magnetic Stimulation Therapy for NeurtherapeuticTLR7/8/9 Antagonists for Neurodegenerationtherapeutic

KG Entities (44)

ADORA2AADRA2AAMPKAQP4ATG5ATG7Astrocyte reactivity signalingBDNFBMAL1CACNA1GCLOCKCX3CR1Circadian rhythm / glymphatic clearanceHCRTHCRTR2HDACHypocretin/orexin wakefulness signalingLC3MAPTMTNR1A

Dependency Graph (3 upstream, 4 downstream)

Depends On
HCN1-Mediated Resonance Frequency Stabilization Therapybuilds_on (1.0)Biorhythmic Interference via Controlled Sleep Oscillationsbuilds_on (1.0)Circadian Glymphatic Entrainment via Targeted Orexin Receptor Modulationbuilds_on (1.0)
Depended On By
Gamma entrainment therapy to restore hippocampal-cortical synchronybuilds_on (1.0)Prefrontal sensory gating circuit restoration via PV interneuron enhancementbuilds_on (1.0)Circadian Glymphatic Rescue Therapy (Melatonin-focused)builds_on (1.0)Hippocampal CA3-CA1 circuit rescue via neurogenesis and synaptic preservationbuilds_on (0.8)

Linked Experiments (10)

Brain Connectivity-Targeted tACS Trial in Early ADclinical | tests | 0.95tACS Connectivity Trial in Early Alzheimer'sclinical | tests | 0.46Neural Oscillation Dysfunction Validation in Parkinson's Diseaseclinical | tests | 0.46Migraine Cortical Hyperexcitability and Alzheimer's Disease Risk: Longitudinal Mclinical | tests | 0.46Sleep and Respiratory Network Interaction in ALS — Experiment Designclinical | tests | 0.46Sleep Disruption and Alzheimer's Disease — mechanism and interventionclinical | tests | 0.46Non-Motor Symptom Progression in Parkinson's Disease — Mechanisms and Biomarkersclinical | tests | 0.46Brain Connectivity-Targeted tACS Trial in Early ADclinical | tests | 0.46DLB Cognitive Fluctuation Mechanism Experimentclinical | tests | 0.46Sleep and Circadian Dysfunction as Driver of Neurodegenerationclinical | tests | 0.46

Related Hypotheses

SASP-Mediated Complement Cascade Amplification
Score: 0.703 | neurodegeneration
TREM2-Dependent Microglial Senescence Transition
Score: 0.692 | neurodegeneration
H2: Indole-3-Propionate (IPA) as the Actual Neuroprotective Effector
Score: 0.675 | neurodegeneration
Nutrient-Sensing Epigenetic Circuit Reactivation
Score: 0.670 | neurodegeneration
Transcriptional Autophagy-Lysosome Coupling
Score: 0.665 | neurodegeneration

Estimated Development

Estimated Cost
$15M
Timeline
4.0 years

🧪 Falsifiable Predictions (21)

21 total 0 confirmed 0 falsified
Selective AQP4 upregulation without sleep improvement in transgenic models
pending conf: 0.45
Expected outcome: Confirmatory evidence for hypothesis
Falsified by: Failure of: Selective AQP4 upregulation without sleep improvement in transgenic models
Glymphatic enhancement in awake states showing equal clearance benefits
pending conf: 0.45
Expected outcome: Confirmatory evidence for hypothesis
Falsified by: Failure of: Glymphatic enhancement in awake states showing equal clearance benefits
Long-term AQP4 modulation studies showing no cognitive protection
pending conf: 0.45
Expected outcome: Confirmatory evidence for hypothesis
Falsified by: Failure of: Long-term AQP4 modulation studies showing no cognitive protection
OR2 agonist treatment worsening sleep quality despite microglial changes
pending conf: 0.45
Expected outcome: Confirmatory evidence for hypothesis
Falsified by: Failure of: OR2 agonist treatment worsening sleep quality despite microglial changes
Orexin enhancement accelerating rather than slowing neurodegeneration
pending conf: 0.45
Expected outcome: Confirmatory evidence for hypothesis
Falsified by: Failure of: Orexin enhancement accelerating rather than slowing neurodegeneration
Microglial depletion preventing orexin-mediated benefits
pending conf: 0.45
Expected outcome: Confirmatory evidence for hypothesis
Falsified by: Failure of: Microglial depletion preventing orexin-mediated benefits
A2A antagonists providing superior cognitive protection than agonists
pending conf: 0.45
Expected outcome: Confirmatory evidence for hypothesis
Falsified by: Failure of: A2A antagonists providing superior cognitive protection than agonists
Metabolic enhancement without sleep improvement showing no neuroprotection
pending conf: 0.45
Expected outcome: Confirmatory evidence for hypothesis
Falsified by: Failure of: Metabolic enhancement without sleep improvement showing no neuroprotection
Adenosine system manipulation having no effect on established neurodegeneration
pending conf: 0.45
Expected outcome: Confirmatory evidence for hypothesis
Falsified by: Failure of: Adenosine system manipulation having no effect on established neurodegeneration
α2A agonists accelerating cognitive decline despite reducing tau pathology
pending conf: 0.45
Expected outcome: Confirmatory evidence for hypothesis
Falsified by: Failure of: α2A agonists accelerating cognitive decline despite reducing tau pathology
LC lesions preventing rather than promoting tau spread
pending conf: 0.45
Expected outcome: Confirmatory evidence for hypothesis
Falsified by: Failure of: LC lesions preventing rather than promoting tau spread
REM enhancement having no effect on established tau networks
pending conf: 0.45
Expected outcome: Confirmatory evidence for hypothesis
Falsified by: Failure of: REM enhancement having no effect on established tau networks
Circadian restoration without autophagy enhancement showing no benefits
pending conf: 0.45
Expected outcome: Confirmatory evidence for hypothesis
Falsified by: Failure of: Circadian restoration without autophagy enhancement showing no benefits
Autophagy enhancement in circadian-disrupted models providing full protection
pending conf: 0.45
Expected outcome: Confirmatory evidence for hypothesis
Falsified by: Failure of: Autophagy enhancement in circadian-disrupted models providing full protection
Clock gene manipulation worsening neurodegeneration despite improved autophagy
pending conf: 0.45
Expected outcome: Confirmatory evidence for hypothesis
Falsified by: Failure of: Clock gene manipulation worsening neurodegeneration despite improved autophagy
Sleep spindle enhancement without memory improvement in MCI patients
pending conf: 0.45
Expected outcome: Confirmatory evidence for hypothesis
Falsified by: Failure of: Sleep spindle enhancement without memory improvement in MCI patients
T-type channel modulation causing seizures or cardiac arrhythmias
pending conf: 0.45
Expected outcome: Confirmatory evidence for hypothesis
Falsified by: Failure of: T-type channel modulation causing seizures or cardiac arrhythmias
Spindle-independent memory consolidation pathways providing equal benefits
pending conf: 0.45
Expected outcome: Confirmatory evidence for hypothesis
Falsified by: Failure of: Spindle-independent memory consolidation pathways providing equal benefits
Neurogenesis enhancement without cognitive benefits in human studies
pending conf: 0.45
Expected outcome: Confirmatory evidence for hypothesis
Falsified by: Failure of: Neurogenesis enhancement without cognitive benefits in human studies
Hypocretin modulation disrupting rather than improving sleep architecture
pending conf: 0.45
Expected outcome: Confirmatory evidence for hypothesis
Falsified by: Failure of: Hypocretin modulation disrupting rather than improving sleep architecture
BDNF manipulation causing adverse neurological effects
pending conf: 0.45
Expected outcome: Confirmatory evidence for hypothesis
Falsified by: Failure of: BDNF manipulation causing adverse neurological effects

Knowledge Subgraph (192 edges)

associated with (4)

ADORA2A neurodegeneration
ADRA2A neurodegeneration
CACNA1G neurodegeneration
HCRT neurodegeneration

causes (1)

MAPT tau_pathology

co associated with (21)

ADORA2A HCRT
ADORA2A HCRTR2
ADORA2A CACNA1G
ADORA2A CLOCK
ADORA2A MTNR1A
...and 16 more

co discussed (141)

BMAL1 HCRTR2
BMAL1 BDNF
BMAL1 AQP4
BMAL1 MTNR1A
BMAL1 CX3CR1
...and 136 more

co regulates (1)

CLOCK TFEB

controls (2)

adenosine_metabolism sleep_homeostasis
CX3CR1 microglial_activation

generates (1)

CACNA1G sleep_spindles

implicated in (7)

h-41bc2d38 neurodegeneration
h-de579caf neurodegeneration
h-b7898b79 neurodegeneration
h-4113b0e8 neurodegeneration
h-8597755b neurodegeneration
...and 2 more

mediates (1)

AQP4 glymphatic_clearance

modulates via microglia (1)

HCRTR2 CX3CR1

participates in (6)

ADORA2A Astrocyte reactivity signaling
MTNR1A Circadian rhythm / glymphatic clearance
ADRA2A Tau protein / microtubule-associated pathway
HCRTR2 Microglial activation / TREM2 signaling
CACNA1G Synaptic function / plasticity
...and 1 more

promoted: Adenosine-Astrocyte Metabolic Reset (1)

ADORA2A neurodegeneration

promotes (2)

glymphatic_clearance amyloid_beta_clearance
sleep_spindles memory_consolidation

regulates (1)

ADORA2A adenosine_metabolism

regulates expression (1)

MTNR1A AQP4

regulates propagation (1)

ADRA2A MAPT

Mechanism Pathway for CACNA1G

Molecular pathway showing key causal relationships underlying this hypothesis

graph TD
    CACNA1G["CACNA1G"] -->|generates| sleep_spindles["sleep_spindles"]
    CACNA1G_1["CACNA1G"] -->|associated with| neurodegeneration["neurodegeneration"]
    CACNA1G_2["CACNA1G"] -->|participates in| Synaptic_function___plast["Synaptic function / plasticity"]
    BMAL1["BMAL1"] -->|co discussed| CACNA1G_3["CACNA1G"]
    HCRTR2["HCRTR2"] -->|co discussed| CACNA1G_4["CACNA1G"]
    CLOCK["CLOCK"] -->|co discussed| CACNA1G_5["CACNA1G"]
    BDNF["BDNF"] -->|co discussed| CACNA1G_6["CACNA1G"]
    AQP4["AQP4"] -->|co discussed| CACNA1G_7["CACNA1G"]
    MTNR1A["MTNR1A"] -->|co discussed| CACNA1G_8["CACNA1G"]
    CX3CR1["CX3CR1"] -->|co discussed| CACNA1G_9["CACNA1G"]
    HCRT["HCRT"] -->|co discussed| CACNA1G_10["CACNA1G"]
    CACNA1G_11["CACNA1G"] -->|co discussed| ADORA2A["ADORA2A"]
    CACNA1G_12["CACNA1G"] -->|co discussed| ADRA2A["ADRA2A"]
    CACNA1G_13["CACNA1G"] -->|co discussed| HCRT_14["HCRT"]
    CACNA1G_15["CACNA1G"] -->|co discussed| AQP4_16["AQP4"]
    style CACNA1G fill:#ce93d8,stroke:#333,color:#000
    style sleep_spindles fill:#4fc3f7,stroke:#333,color:#000
    style CACNA1G_1 fill:#ce93d8,stroke:#333,color:#000
    style neurodegeneration fill:#ef5350,stroke:#333,color:#000
    style CACNA1G_2 fill:#ce93d8,stroke:#333,color:#000
    style Synaptic_function___plast fill:#81c784,stroke:#333,color:#000
    style BMAL1 fill:#ce93d8,stroke:#333,color:#000
    style CACNA1G_3 fill:#ce93d8,stroke:#333,color:#000
    style HCRTR2 fill:#ce93d8,stroke:#333,color:#000
    style CACNA1G_4 fill:#ce93d8,stroke:#333,color:#000
    style CLOCK fill:#ce93d8,stroke:#333,color:#000
    style CACNA1G_5 fill:#ce93d8,stroke:#333,color:#000
    style BDNF fill:#ce93d8,stroke:#333,color:#000
    style CACNA1G_6 fill:#ce93d8,stroke:#333,color:#000
    style AQP4 fill:#ce93d8,stroke:#333,color:#000
    style CACNA1G_7 fill:#ce93d8,stroke:#333,color:#000
    style MTNR1A fill:#ce93d8,stroke:#333,color:#000
    style CACNA1G_8 fill:#ce93d8,stroke:#333,color:#000
    style CX3CR1 fill:#ce93d8,stroke:#333,color:#000
    style CACNA1G_9 fill:#ce93d8,stroke:#333,color:#000
    style HCRT fill:#ce93d8,stroke:#333,color:#000
    style CACNA1G_10 fill:#ce93d8,stroke:#333,color:#000
    style CACNA1G_11 fill:#ce93d8,stroke:#333,color:#000
    style ADORA2A fill:#ce93d8,stroke:#333,color:#000
    style CACNA1G_12 fill:#ce93d8,stroke:#333,color:#000
    style ADRA2A fill:#ce93d8,stroke:#333,color:#000
    style CACNA1G_13 fill:#ce93d8,stroke:#333,color:#000
    style HCRT_14 fill:#ce93d8,stroke:#333,color:#000
    style CACNA1G_15 fill:#ce93d8,stroke:#333,color:#000
    style AQP4_16 fill:#ce93d8,stroke:#333,color:#000

3D Protein Structure

🧬 CACNA1G — PDB 6KZO Click to expand 3D viewer

Experimental structure from RCSB PDB | Powered by Mol* | Rotate: click+drag | Zoom: scroll | Reset: right-click

Source Analysis

Sleep disruption as cause and consequence of neurodegeneration

neurodegeneration | 2026-04-01 | completed